Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IPA announces leadership transition
Sharvil Patel, MD, Zydus Lifesciences and former VP, IPA, assumes the role of President,; Glenn Saldanha, Chairman and MD,…
Supriya Lifescience receives WHO GMP Certification for Ambernath Facility
Approval enables commercial production of formulations with projected revenue potential of ₹500 crore
AI compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…
Understanding real-world microbiological outcomes will guide long-term CFTR modulator use in CF:…
Real-world microbiological data reveal complex trends in CFTR modulator therapy, highlighting the need for tailored long-term…
Driving India’s innovation edge
Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma…
Panel Discussion: Moving up the value chain without losing volume advantage
India has earned global recognition for making affordable medicines available at scale. But the big question now is: can India…
Next-gen CDMOs: What will they look like
Dr Huzaifa S Choonia, Director & Head, Drug Substance-MSAT, OneSource, spoke on how next generation contract development and…
Secure your Pharma QC-reference standards
The Bengaluru Pharma Event 2025 also featured a detailed session by Dr Markus Obkircher, Director, Head of Customer Solutions…
The R&D playbook for complex generics
Dr Rakesh Bhasin, Head R&D (Formulations), Biocon, gave a presentation on 'The R&D playbook for complex generics'. He…
Panel Discussion: Bengaluru: An emerging global innovation gateway?
Bengaluru, known globally as India’s IT capital, is now fast emerging as a powerful hub for pharma and life sciences. With its…